Navigation Links
UNM Cancer Center researchers study new target for breast cancer
Date:12/4/2012

Physiology and a member of the Women's Cancers Program, to conduct studies on GPER. In the first study, Drs. Prossnitz and Hathaway will use cancerous and non-cancerous breast cells to discover the differences in biochemical reactions that estrogen receptors and GPER trigger. Both receptors ultimately stimulate enzymes that regulate cell growth and survival, but researchers know little about how the cascades of cellular reactions differ. Understanding this biochemistry will help Drs. Prossnitz and Hathaway explain how breast cancer cells respond to estrogen and become resistant to Tamoxifen, potentially resulting in better long-term breast cancer therapies.

In the second set of studies, Drs. Prossnitz and Hathaway will use mice lacking the gene for GPER to determine whether GPER affects how breast cancers form and progress. They will also evaluate whether GPER affects the ability of the primary tumors to metastasize. Dr. Prossnitz explains, "The primary tumor rarely kills women. But when the tumor spreads to another site in the body and affects the function of an organ, that can kill." Drs. Prossnitz and Hathaway will also test different combinations of drugs to develop potential therapies that could inhibit both ER-a, the dominant estrogen receptor in breast cancers, and GPER receptors. Such a therapy could prevent acquired resistance to existing breast cancer drugs and targeting GPER alone could be a new strategy for triple negative breast cancers.

In their final set of studies, Drs. Prossnitz and Hathaway will use small pieces of live human breast tumors and normal breast tissue to test different therapies and GPER function. These small pieces of tissue include not only the breast cells, cancerous or not, but also the surrounding cells and matrix. "Cells behave very differently in tissues," explains Dr. Prossnitz. "They respond to what their neighbors are doing, and to the kinds of neighboring cells. To understand their behavior in people, we h
'/>"/>

Contact: Michele Sequeira
MSequeira@salud.unm.edu
505-925-0486
University of New Mexico Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... 2015 Compare-autoinsurance.org has released a new blog post ... auto insurance policy . , Some types of vehicles ... check the newly released blog post to see if their vehicle ... damaged vehicles are some of the cars that cannot be covered ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Sept. 1 (HealthDay News) -- The intensity of exercise, not ... chances of living a longer life, a new study suggests. ... men with high levels of cycling intensity lived 5.3 years ... than men with low intensity. Among female cyclists, those ...
... DARIEN, IL A natural yellowing of the eye lens that ... group of test volunteers, according to a,study in the September 1 ... lens discoloration worsened with age, so did the risk of insomnia. ... explain why sleep disorders become more frequent with increasing age," said ...
... adults aged 15 to 44 increased up to 37% ... by researchers at the Centers for Disease Control and ... of Neurology , a journal of the American Neurological ... in the prevalence of hypertension, diabetes, obesity, lipid disorders, ...
... in the September issue of the Journal of the ... optimization in chest computed tomography (CT) scans. Chest CT is ... diagnose the cause of clinical signs or symptoms of the ... fever. Regardless of the body region being scanned, ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, ... using electronic medical records instead of paper files could ... Diabetic patients "did better and improved faster" at ... e-records, said study author Dr. Randall D. Cebul, a ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- A new type of ... tumor cells without harming normal cells is showing promise in ... 23 patients with advanced cancers that had spread to multiple ... received an intravenous infusion of a virus called JX-594 at ...
Cached Medicine News:Health News:Aging eyes linked to sleepless nights, new study shows 2Health News:Increased prevalence of stroke hospitalizations seen in teens and young adults 2Health News:Electronic Medical Records Might Boost Diabetes Care 2Health News:Electronic Medical Records Might Boost Diabetes Care 3Health News:Trial of Cancer-Fighting Virus Shows Promise 2Health News:Trial of Cancer-Fighting Virus Shows Promise 3
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... JUNCTION, N.J. , Jan. 23, 2015  CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... patients, announced the receipt of $385,642, net of ... participant of the Technology Business Tax Certificate Transfer ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... at 8 am versus placebo: - 25,/ - ... Blood pressure reduction dependent on vaccine dose and ... today at the Seventeenth European,Meeting on Hypertension in ... Italy, June 17, 2007 -,Cytos Biotechnology AG (SWX:CYTN) ...
... WIRE)--Jun 18, 2007 - Advanced Viral,Research Corp. ... today that preliminary findings from its ongoing,Phase ... AVR118,appears to have clinical activity in reducing ... dermatologic,dermabrasion., The Phase II open label dermatological ...
Cached Medicine Technology:Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 2Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 3Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 4Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 5Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 6Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 7Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 8Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 9Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2
A rapid, convenient, qualitative method for detecting asymptomatic occult bleeding....
... die each year of colon cancer ... improvements (high contrast berium enema, colonoscopy, ... in the success rate of curative ... been achieved over the past two ...
... of guaiac as a test for the presence ... phenolic compounds present in guaiac to quinones, resulting ... blood is present, the heme portion of the ... catalyzing the release of oxygen from hydrogen peroxide ...
... elitewas designed to improve patient compliance. Its ... sample collection options make this fecal occult ... and complete. Diet guidelines are explained in ... which foods and drugs are okay and ...
Medicine Products: